GH1 and aneuploidy: In conclusion, we present preliminary evidence showing that GH supplementation can ameliorate blastocyst aneuploidy and improve pregnancy outcomes in women younger than 40 years who have experienced prior pregnancy failures with aneuploidy rates higher than 50%.